Comment on: Concurrent chemoradiotherapy versus radiotherapy alone in postoperative high-risk adenoid cystic carcinoma of the head and neck: A propensity score-matched analysis.
作者信息
Topkan Erkan, Somay Efsun, Selek Ugur
机构信息
Department of Radiation Oncology, Başkent University, Adana, Turkey.
Department of Oral and Maxillofacial Surgery, Başkent University, Ankara, Turkey.
出版信息
Clin Transl Radiat Oncol. 2025 May 26;53:100982. doi: 10.1016/j.ctro.2025.100982. eCollection 2025 Jul.
Abstract
摘要
相似文献
1
Comment on: Concurrent chemoradiotherapy versus radiotherapy alone in postoperative high-risk adenoid cystic carcinoma of the head and neck: A propensity score-matched analysis.评论：同步放化疗与单纯放疗用于术后高危头颈部腺样囊性癌的疗效比较：一项倾向评分匹配分析
Clin Transl Radiat Oncol. 2025 May 26;53:100982. doi: 10.1016/j.ctro.2025.100982. eCollection 2025 Jul.
2
Platinum-based adjuvant chemoradiotherapy versus adjuvant radiotherapy in patients with head and neck adenoid cystic carcinoma.头颈部腺样囊性癌患者的铂类辅助放化疗与辅助放疗比较。
J Cancer Res Clin Oncol. 2024 Apr 16;150(4):195. doi: 10.1007/s00432-024-05719-0.
3
Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.在涎腺腺样囊性癌患者中，术后放疗联合同期化疗可改善局部区域控制，但不能提高总生存率——一项倾向评分匹配研究
Radiat Oncol. 2016 Mar 22;11:47. doi: 10.1186/s13014-016-0617-7.
4
Concurrent chemoradiotherapy versus radiotherapy alone in postoperative high-risk adenoid cystic carcinoma of the head and neck: A propensity score matched analysis.同步放化疗与单纯放疗治疗术后高危头颈部腺样囊性癌的倾向评分匹配分析
Clin Transl Radiat Oncol. 2025 Mar 17;53:100945. doi: 10.1016/j.ctro.2025.100945. eCollection 2025 Jul.
5
Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis.调强放疗时代局部晚期食管鳞癌同期放化疗与单纯放疗的比较：倾向评分匹配分析。
Thorac Cancer. 2021 Jun;12(12):1831-1840. doi: 10.1111/1759-7714.13971. Epub 2021 May 5.
6
Concurrent chemoradiotherapy for locally advanced unresectable adenoid cystic carcinoma of head and neck: experience from a single institute.头颈部局部晚期不可切除腺样囊性癌的同期放化疗：单中心经验。
Eur Arch Otorhinolaryngol. 2021 Nov;278(11):4423-4431. doi: 10.1007/s00405-021-06654-3. Epub 2021 Feb 9.
7
Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: A series of 9 cases and a critical review of the literature.确定性质子放射治疗联合顺铂治疗不可切除的头颈部腺样囊性癌：9例病例系列及文献综述
Head Neck. 2016 Apr;38 Suppl 1:E1472-80. doi: 10.1002/hed.24262. Epub 2015 Nov 11.
8
Concurrent chemoradiotherapy versus radiotherapy alone in older patients with stage II nasopharyngeal carcinoma after intensity-modulated radiotherapy: A propensity score-matched cohort study.调强放疗后局部晚期老年鼻咽癌患者同期放化疗与单纯放疗的比较：倾向评分匹配队列研究。
Radiother Oncol. 2024 Feb;191:110081. doi: 10.1016/j.radonc.2024.110081. Epub 2024 Jan 5.
9
Patterns of recurrence after low-dose postoperative radiotherapy for head and neck squamous cell carcinoma.头颈部鳞状细胞癌术后低剂量放疗后的复发模式
J Egypt Natl Canc Inst. 2021 Dec 20;33(1):40. doi: 10.1186/s43046-021-00098-w.
10
[Adenoid cystic carcinoma of the head and neck: a retrospective series of 169 cases].[头颈部腺样囊性癌：169例回顾性研究系列]
Cancer Radiother. 2012 Jul-Aug;16(4):247-56. doi: 10.1016/j.canrad.2012.02.003. Epub 2012 May 29.
本文引用的文献
1
Concurrent chemoradiotherapy versus radiotherapy alone in postoperative high-risk adenoid cystic carcinoma of the head and neck: A propensity score matched analysis.同步放化疗与单纯放疗治疗术后高危头颈部腺样囊性癌的倾向评分匹配分析
Clin Transl Radiat Oncol. 2025 Mar 17;53:100945. doi: 10.1016/j.ctro.2025.100945. eCollection 2025 Jul.
2
The impact of different timing of mouth opening exercises on trismus in postoperative radiotherapy patients with oral cancer.不同时机开口练习对口腔癌术后放疗患者牙关紧闭的影响
J Stomatol Oral Maxillofac Surg. 2025 Jun;126(3):102104. doi: 10.1016/j.jormas.2024.102104. Epub 2024 Oct 2.
3
Quality of Life for Osteoradionecrosis Reconstruction in the Head and Neck: A Longitudinal Framework and Risk Factors.头颈部放射性骨坏死重建的生活质量：纵向框架与风险因素
Plast Reconstr Surg. 2025 Apr 1;155(4):695-705. doi: 10.1097/PRS.0000000000011790. Epub 2024 Oct 1.
4
Chemotherapy increases the prevalence of radiotherapy-related trismus in head and neck cancer patients: A systematic review and meta-analysis.化疗增加头颈部癌患者放疗相关牙关紧闭的发生率：一项系统评价和荟萃分析。
J Clin Exp Dent. 2024 Apr 1;16(4):e503-e515. doi: 10.4317/jced.61385. eCollection 2024 Apr.
5
Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland Malignancies.同步放化疗在高危原发性涎腺恶性肿瘤辅助治疗中的应用
Am J Clin Oncol. 2018 Sep;41(9):888-893. doi: 10.1097/COC.0000000000000386.
6
Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.辅助放化疗与单纯放疗对手术切除的大唾液腺癌患者生存率的影响：来自国家癌症数据库的数据
JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1100-1110. doi: 10.1001/jamaoto.2016.2168.
7
Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial Design.现代影像引导调强放疗治疗口咽癌及严重迟发性毒性反应：对临床试验设计的影响。
JAMA Otolaryngol Head Neck Surg. 2016 Dec 1;142(12):1164-1170. doi: 10.1001/jamaoto.2016.1876.
8
Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas.辅助放疗与同步放化疗治疗高危涎腺癌的疗效比较
Head Neck. 2016 Nov;38(11):1628-1633. doi: 10.1002/hed.24484. Epub 2016 Apr 21.
Zotero 插件